Effect of of escitalopram and relaxation on hot flashes of patients with breast cancer
Phase 3
Recruiting
- Conditions
- Hot Flash.Menopausal and female climacteric states
- Registration Number
- IRCT2017072834482N2
- Lead Sponsor
- Vice chancellor for Research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 87
Inclusion Criteria
having at least 4 hot flash attacks daily; Age range is 18 to 65 years; a history of breast cancer; not in acute phase of breast cancer, Ability to read and write and being able to answer questions ;Consent to participate in the study; Not concurrent using of any drugs that affect hot flash symptoms such as gabapentin, pregabalin, clonidine, SSRIs, herbal drugs and other treatments such as acupuncture, hypnotism ; no Non-malignant hypertension or CVA or MI or other uncontrolled organic problems and psychotic or bipolar disorders
Exclusion criteria: incidence of intolerable drug side effects, breast cancer relapse needing chemotherapy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hotflash frequency. Timepoint: before treatment and 4 weeks after treatment. Method of measurement: Hotflash diary.
- Secondary Outcome Measures
Name Time Method Hotflash duration. Timepoint: before treatment and 4 weeks after treatment. Method of measurement: Hotflash diary.